SUPERNUS PHARMACEUTICALS INC 4
4 · SUPERNUS PHARMACEUTICALS INC · Filed Jun 15, 2017
Insider Transaction Report
Form 4
Nuerge William A.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2017-06-13+6,036→ 6,036 totalExercise: $38.60From: 2018-06-13Exp: 2027-06-13→ Common Stock (6,036 underlying)
Holdings
- 23,750
Common Stock